Prevention of platelet aggregation in patients with prostatic cancer during estrogen therapy.
D000368:Aged; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000378:metabolism; D000242:Cyclic AMP / Q000097:blood; D004176:Dipyridamole / Q000627:therapeutic use*; D005342:Fibrinolysis; D006589:Hexestrol / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects*; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy*; D012306:Risk; D013927:Thrombosis / Q000517:prevention & control*
D006589:Hexestrol; D004176:Dipyridamole; D000242:Cyclic AMP